NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
3.210
-0.030 (-0.93%)
At close: Feb 13, 2026, 4:00 PM EST
3.300
+0.090 (2.80%)
After-hours: Feb 13, 2026, 7:21 PM EST
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $370.08 million as of February 13, 2026. Its market cap has increased by 328.73% in one year.
Market Cap
370.08M
Enterprise Value
145.09M
1-Year Change
328.73%
Ranking
Category
Stock Price
$3.21
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $370.08M, an increase of 168.08%. That is a compound annual growth rate of 17.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 370.08M | -19.35% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immix Biopharma | 391.53M |
| Benitec Biopharma | 388.45M |
| Entrada Therapeutics | 387.30M |
| Bicycle Therapeutics | 371.81M |
| Autolus Therapeutics | 367.28M |
| Allogene Therapeutics | 364.06M |
| Aclaris Therapeutics | 364.04M |
| Absci | 363.90M |